-
81
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases
Published 2025-02-01“…In this review, the research history and milestone events of studying metal ions, including iron, manganese, copper, and zinc in neurodegenerative diseases such as Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD), will be introduced. …”
Get full text
Article -
82
Tumor Necrosis Factor Alpha: A Link between Neuroinflammation and Excitotoxicity
Published 2014-01-01“…This review summarizes the current knowledge of the cellular and molecular mechanisms by which TNF-α links the neuroinflammatory and excitotoxic processes that occur in several neurodegenerative diseases, but with a special emphasis on amyotrophic lateral sclerosis (ALS). As microglial activation and upregulation of TNF-α expression is a common feature of several CNS diseases, as well as chronic opioid exposure and neuropathic pain, modulating TNF-α signaling may represent a valuable target for intervention.…”
Get full text
Article -
83
VDAC1: A Key Player in the Mitochondrial Landscape of Neurodegeneration
Published 2024-12-01“…Accordingly, increasing evidence suggests that VDAC1 is implicated in the pathophysiology of neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and others. This review summarizes the current findings on the contribution of VDAC1 to neurodegeneration, focusing on its interactions with disease-specific proteins, such as amyloid-β, α-synuclein, and mutant SOD1. …”
Get full text
Article -
84
Peripheral proteinopathy in neurodegenerative diseases
Published 2025-01-01“…Abstract Proteinopathies in neurology typically refer to pathological changes in proteins associated with neurological diseases, such as the aggregation of amyloid β and Tau in Alzheimer’s disease, α-synuclein in Parkinson’s disease and multiple system atrophy, and TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal dementia. Interestingly, these proteins are also commonly found in peripheral tissues, raising important questions about their roles in neurological disorders. …”
Get full text
Article -
85
Acute β-N-Methylamino-L-alanine Toxicity in a Mouse Model
Published 2015-01-01“…Long-term exposure to L-BMAA is believed to lead to neurodegenerative diseases including Parkinson’s and Alzheimer’s diseases and amyotrophic lateral sclerosis (Lou Gehrig’s disease). Objectives of this study were to determine the presumptive median lethal dose (LD50), the Lowest-Observed-Adverse-Effect Level (LOAEL), and histopathologic lesions caused by the naturally occurring BMAA isomer, L-BMAA, in mice. …”
Get full text
Article -
86
Treatment with Herbal Formula Extract in the hSOD1G93A Mouse Model Attenuates Muscle and Spinal Cord Dysfunction via Anti-Inflammation
Published 2022-01-01“…Amyotrophic lateral sclerosis (ALS), a multicomplex neurodegenerative disease, has multiple underlying pathological factors and can induce other neuromuscular diseases, leading to muscle atrophy and respiratory failure. …”
Get full text
Article -
87
M1 and M2 Functional Imprinting of Primary Microglia: Role of P2X7 Activation and miR-125b
Published 2016-01-01“…Amyotrophic lateral sclerosis (ALS) is a most frequently occurring and severe form of motor neuron disease, causing death within 3–5 years from diagnosis and with a worldwide incidence of about 2 per 100,000 person-years. …”
Get full text
Article -
88
Enhancing ALS disease management: exploring integrated user value through online communities evidence
Published 2025-01-01“…IntroductionAssistive technologies (ATs) offer significant potential to improve the quality of life for individuals with Amyotrophic Lateral Sclerosis (ALS). This study explores the concept of integrated user value (IUV), focusing on five key aspects: quality, user experience, cost-effectiveness, safety, and accessibility. …”
Get full text
Article -
89
Mutations in human prion-like domains: pathogenic but not always amyloidogenic
Published 2024-12-01“…To date, over 60 mutations targeting the LCDs of hnRNPs have been identified and associated with a spectrum of neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer’s disease (AD). …”
Get full text
Article -
90
More than just a number: the gut microbiota and brain function across the extremes of life
Published 2024-12-01“…Longitudinal interventions are being conducted in AD, PD, amyotrophic lateral sclerosis, Huntington's disease, and multiple sclerosis. …”
Get full text
Article -
91
A guide to selecting high-performing antibodies for VAPB (UniProt ID: O95292) for use in western blot, immunoprecipitation, and immunofluorescence [version 1; peer review: 3 approv...
Published 2024-12-01“…A mutant form of VAPB has been linked to amyotrophic lateral sclerosis and the underlying mechanisms resulting from this defect are studied by researchers in this area to uncover its implication in the disease. …”
Get full text
Article -
92
Unveiling the role of SYNGR4 in breast cancer development: a novel target for immunotherapy
Published 2025-01-01“…IntroductionSYNGR4 is considered to be one of the causative genes for amyotrophic lateral sclerosis, but its role in breast cancer development has not been revealed.MethodsThe expression of SYNGR4 in a variety of malignancies including breast cancer was analyzed using Genotype Tissue Expression (GTEx) and the Cancer Genome Atlas (TCGA) databases and verified by specimens collected from our center. …”
Get full text
Article -
93
Anti-Inflammatory and Neuroprotective Role of Natural Product Securinine in Activated Glial Cells: Implications for Parkinson’s Disease
Published 2017-01-01“…Securinine, a major natural alkaloid product from the root of the plant Securinega suffruticosa, has been reported to have potent biological activity and is used in the treatment of neurological conditions such as amyotrophic lateral sclerosis, poliomyelitis, and multiple sclerosis. …”
Get full text
Article -
94
Glymphatic dysfunction and neurodegeneration in ALS: Longitudinal insights from rNLS8 TDP-43 mice
Published 2025-03-01“…Dysfunctional Tar DNA binding protein-43 (TDP-43) is found in approximately 95 % of all people with amyotrophic lateral sclerosis (ALS). Recent evidence suggests that the glymphatic system, which clears the brain of waste proteins, is impaired in ALS and may contribute to the accumulation of TDP-43. …”
Get full text
Article -
95
CD22 modulation alleviates amyloid β-induced neuroinflammation
Published 2025-02-01“…Abstract Neuroinflammation is a crucial driver of multiple neurodegenerative diseases, including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD). …”
Get full text
Article -
96
In vivo mapping of sodium homeostasis disturbances in individual ALS patients: A brain 23Na MRI study.
Published 2025-01-01“…<h4>Objective</h4>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by significant heterogeneity among patients. 23Na MRI maps abnormal sodium homeostasis that reflects metabolic alterations and energetic failure contributing to the neurodegenerative process. …”
Get full text
Article -
97
TDP-43 as a potential retinal biomarker for neurodegenerative diseases
Published 2025-02-01“…These include amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration (FTLD), Alzheimer’s disease (AD), chronic traumatic encephalopathy (CTE), and others. …”
Get full text
Article -
98
Kaempferol enhances ER-mitochondria coupling and protects motor neurons from mitochondrial dysfunction and ER stress in C9ORF72-ALS
Published 2025-02-01“…Abstract Repeat expansions in the C9ORF72 gene are a frequent cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. …”
Get full text
Article -
99
Fatigue and Mental Status of Caregivers of Severely Chronically Ill Patients
Published 2020-01-01“…., dementia, amyotrophic lateral sclerosis, and Parkinson’s disease). The degree of fatigue was measured using the Korean version of the multidimensional fatigue inventory (MFI-K). …”
Get full text
Article -
100
Genetic evidence for the liver-brain axis: lipid metabolism and neurodegenerative disease risk
Published 2025-02-01“…A systematic investigation of the genetic relationship between lipid metabolism abnormalities and ND, namely, Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS), is lacking. To assess potential causal links between ND and six lipid parameters, two-sample Mendelian randomization (MR) was used. …”
Get full text
Article